Mikhail Murashko, Russia’s Minister of Health, has confirmed that the phase of clinical trials of the vaccine developed by the National Research Center for Epidemiology and Microbiology Gamaleya in conjunction with the Russian Ministry of Defense has been completed. The package of documents needed to register the medication is now being prepared.
Once the registration certificate is obtained, the vaccine will begin to be supplied to the population. The first to be vaccinated will be members of special groups such as doctors and teachers. “There will be more observations from vaccinated patients,” Murashko explained, adding that mass vaccination is scheduled for October.
The Defense Ministry emphasized that the trial results unequivocally show the development of an immune response in all volunteers, with no side effects, complications or unwanted reactions.
The Health Minister also said that another vaccine, developed by the Véktor State Center for Research in Virology and Biotechnology in Novosibirsk, is undergoing clinical trials.
Last week, Russian Prime Minister Mikhail Mishustin announced that 17 scientific organizations in the country are developing more than 25 different vaccines against the new coronavirus. So far, Russia has recorded 845,443 positive cases and 14,058 deaths from covid-19.
— Erick Toribio to www.cachicha.com